High bone mass osteogenesis imperfecta

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:314029Q78.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

High bone mass osteogenesis imperfecta (OI) is a rare genetic bone disorder that belongs to the broader group of conditions known as osteogenesis imperfecta, sometimes called "brittle bone disease." Unlike the more common forms of OI where bones are fragile and break easily, high bone mass OI is unusual because the bones are actually denser than normal yet still prone to fractures. This happens because the bone tissue, while abundant, is not properly organized or of normal quality. People with high bone mass OI may experience bone fractures from mild trauma, particularly during childhood. They may also have short stature, bone deformities, and thickened or dense-appearing bones on X-rays. The whites of the eyes (sclera) may appear normal or slightly blue. Some individuals develop hearing loss over time. The condition is caused by specific mutations in genes that produce type I collagen, the main structural protein in bone. Treatment focuses on preventing fractures, managing pain, and supporting mobility. Bisphosphonate medications may be used to improve bone strength, and physical therapy plays an important role. Orthopedic surgery, including the placement of metal rods in long bones, may be needed for severe or recurrent fractures. While there is no cure, many people with this condition can lead active lives with appropriate medical support and monitoring.

Also known as:

Key symptoms:

Bones that break easily, sometimes from minor injuriesUnusually dense or thick bones seen on X-raysShort stature or growth problemsBone deformities, especially in the arms and legsHearing loss that may develop over timeJoint looseness or hypermobilityMuscle weaknessBone painCurved or bowed long bonesScoliosis or other spine curvatureDental problems such as brittle or discolored teethWaddling gait or difficulty walking

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for High bone mass osteogenesis imperfecta.

View clinical trials →

No actively recruiting trials found for High bone mass osteogenesis imperfecta at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the High bone mass osteogenesis imperfecta community →

No specialists are currently listed for High bone mass osteogenesis imperfecta.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to High bone mass osteogenesis imperfecta.

Search all travel grants →NORD Financial Assistance ↗

Community

Open High bone mass osteogenesis imperfectaForum →

No community posts yet. Be the first to share your experience with High bone mass osteogenesis imperfecta.

Start the conversation →

Latest news about High bone mass osteogenesis imperfecta

No recent news articles for High bone mass osteogenesis imperfecta.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific genetic mutation does my child have, and how does it affect bone quality?,Are bisphosphonates appropriate for this type of OI, given that bone density is already high?,What activities are safe, and which should be avoided to reduce fracture risk?,How often should we have bone density scans, hearing tests, and orthopedic check-ups?,Should other family members be tested for this condition?,Are there any clinical trials or new treatments being studied for this form of OI?,What should we do if we suspect a new fracture has occurred?

Common questions about High bone mass osteogenesis imperfecta

What is High bone mass osteogenesis imperfecta?

High bone mass osteogenesis imperfecta (OI) is a rare genetic bone disorder that belongs to the broader group of conditions known as osteogenesis imperfecta, sometimes called "brittle bone disease." Unlike the more common forms of OI where bones are fragile and break easily, high bone mass OI is unusual because the bones are actually denser than normal yet still prone to fractures. This happens because the bone tissue, while abundant, is not properly organized or of normal quality. People with high bone mass OI may experience bone fractures from mild trauma, particularly during childhood. The

How is High bone mass osteogenesis imperfecta inherited?

High bone mass osteogenesis imperfecta follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.